These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24558349)

  • 1. Pre-B cell receptor signaling induces immunoglobulin κ locus accessibility by functional redistribution of enhancer-mediated chromatin interactions.
    Stadhouders R; de Bruijn MJ; Rother MB; Yuvaraj S; Ribeiro de Almeida C; Kolovos P; Van Zelm MC; van Ijcken W; Grosveld F; Soler E; Hendriks RW
    PLoS Biol; 2014 Feb; 12(2):e1001791. PubMed ID: 24558349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A B-Cell-Specific Enhancer Orchestrates Nuclear Architecture to Generate a Diverse Antigen Receptor Repertoire.
    Barajas-Mora EM; Kleiman E; Xu J; Carrico NC; Lu H; Oltz EM; Murre C; Feeney AJ
    Mol Cell; 2019 Jan; 73(1):48-60.e5. PubMed ID: 30449725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.
    Lazorchak AS; Schlissel MS; Zhuang Y
    Mol Cell Biol; 2006 Feb; 26(3):810-21. PubMed ID: 16428437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Control of Long-Range Genomic Interactions at the Immunoglobulin κ Light-Chain Locus.
    Ribeiro de Almeida C; Hendriks RW; Stadhouders R
    Adv Immunol; 2015; 128():183-271. PubMed ID: 26477368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation.
    Shaffer AL; Peng A; Schlissel MS
    Immunity; 1997 Feb; 6(2):131-43. PubMed ID: 9047235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2A and CBP/p300 act in synergy to promote chromatin accessibility of the immunoglobulin κ locus.
    Sakamoto S; Wakae K; Anzai Y; Murai K; Tamaki N; Miyazaki M; Miyazaki K; Romanow WJ; Ikawa T; Kitamura D; Yanagihara I; Minato N; Murre C; Agata Y
    J Immunol; 2012 Jun; 188(11):5547-60. PubMed ID: 22544934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ig kappa 3' enhancer is activated by gradients of chromatin accessibility and protein association.
    McDevit DC; Perkins L; Atchison ML; Nikolajczyk BS
    J Immunol; 2005 Mar; 174(5):2834-42. PubMed ID: 15728493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Enhancer Marks and Transcription Factor Binding Influence Vκ Gene Rearrangement in Pre-B Cells and Pro-B Cells.
    Kleiman E; Loguercio S; Feeney AJ
    Front Immunol; 2018; 9():2074. PubMed ID: 30271408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin kappa enhancers are differentially regulated at the level of chromatin structure.
    Nikolajczyk BS; Sardi SH; Tumang JR; Ganley-Leal LM
    Mol Immunol; 2007 Jul; 44(13):3407-15. PubMed ID: 17382392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic changes in accessibility, nuclear positioning, recombination, and transcription at the Ig kappa locus.
    Fitzsimmons SP; Bernstein RM; Max EE; Skok JA; Shapiro MA
    J Immunol; 2007 Oct; 179(8):5264-73. PubMed ID: 17911612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAG2 involves the Igκ locus demethylation during B cell development.
    Wu C; Dong Y; Zhao X; Zhang P; Zheng M; Zhang H; Li S; Jin Y; Ma Y; Ren H; Ji Y
    Mol Immunol; 2017 Aug; 88():125-134. PubMed ID: 28641141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.
    Liu Z; Garrard WT
    Mol Cell Biol; 2005 Apr; 25(8):3220-31. PubMed ID: 15798207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-B-cell leukemias in Btk/Slp65-deficient mice arise independently of ongoing V(D)J recombination activity.
    Ta VB; de Haan AB; de Bruijn MJ; Dingjan GM; Hendriks RW
    Leukemia; 2011 Jan; 25(1):48-56. PubMed ID: 21030983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA-binding protein CTCF limits proximal Vκ recombination and restricts κ enhancer interactions to the immunoglobulin κ light chain locus.
    Ribeiro de Almeida C; Stadhouders R; de Bruijn MJ; Bergen IM; Thongjuea S; Lenhard B; van Ijcken W; Grosveld F; Galjart N; Soler E; Hendriks RW
    Immunity; 2011 Oct; 35(4):501-13. PubMed ID: 22035845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical roles of the immunoglobulin intronic enhancers in maintaining the sequential rearrangement of IgH and Igk loci.
    Inlay MA; Lin T; Gao HH; Xu Y
    J Exp Med; 2006 Jul; 203(7):1721-32. PubMed ID: 16785310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of activation and recombination of the murine Igkappa locus.
    Schlissel MS
    Immunol Rev; 2004 Aug; 200():215-23. PubMed ID: 15242407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epigenetic profile of Ig genes is dynamically regulated during B cell differentiation and is modulated by pre-B cell receptor signaling.
    Xu CR; Feeney AJ
    J Immunol; 2009 Feb; 182(3):1362-9. PubMed ID: 19155482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin opening is tightly linked to enhancer activation at the kappa light chain locus.
    Grange S; Boyes J
    Biochem Biophys Res Commun; 2007 Nov; 363(1):223-8. PubMed ID: 17868643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription.
    Zhou X; Xiang Y; Garrard WT
    J Immunol; 2010 Dec; 185(12):7544-52. PubMed ID: 21076060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
    Hodawadekar S; Park K; Farrar MA; Atchison ML
    J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.